Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- 12 July 2016
- journal article
- practice guideline
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 316 (2), 191-210
- https://doi.org/10.1001/jama.2016.8900
Abstract
There have been substantial advances in the use of antiretroviral drugs (ARVs) for the treatment and prevention of HIV infection since the last version of these recommendations in 2014,1 warranting an update to the recommendations.Keywords
This publication has 110 references indexed in Scilit:
- Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial.Journal of Consulting and Clinical Psychology, 2012
- Timing of Antiretroviral Therapy for HIV-1 Infection and TuberculosisThe New England Journal of Medicine, 2011
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyThe New England Journal of Medicine, 2011
- Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trialDrug and Alcohol Dependence, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010
- Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trialThe Lancet, 2010
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysisThe Lancet, 2010
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 TherapyThe New England Journal of Medicine, 2009
- A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.Health Psychology, 2009
- Treatment for Adult HIV InfectionJAMA, 2004